Doximity Reports Mixed FY26 Results, Authorizes New $500M Buyback, Appoints New CFO & President, Settles Lawsuit
summarizeSummary
Doximity reported mixed fiscal year 2026 results with slowing revenue growth and declining net income, but announced a new $500 million share repurchase program, appointed new executive leadership, and settled a major securities lawsuit.
check_boxKey Events
-
Mixed Fiscal Year 2026 Financial Results
Revenue grew 13% to $644.9 million, but net income decreased 12% to $196.1 million. Adjusted EBITDA increased to $357.8 million, maintaining a 55% margin, and operating cash flow rose to $326.5 million.
-
New $500 Million Share Repurchase Program
The Board authorized a new program on February 3, 2026, to repurchase up to $500 million of Class A common stock, with $492.5 million remaining as of March 31, 2026. This follows the completion of a prior $500 million program.
-
Key Executive Appointments
Matt Sonefeldt was appointed Chief Financial Officer and Steven Zatz, MD, was appointed President, both effective May 13, 2026, with significant equity incentives.
-
Securities Lawsuit Settlement
A securities class action lawsuit, initiated in April 2024, was settled on December 24, 2025, for $31 million, fully covered by the company's insurance.
auto_awesomeAnalysis
Doximity's annual report reveals a mixed financial picture with slowing revenue growth and a decline in net income, indicating some operational headwinds. However, the company is actively addressing these challenges through strategic initiatives, including a new $500 million share repurchase program, which signals confidence in future value. The appointment of a new CFO and President strengthens leadership, and the acquisition of an AI platform underscores a commitment to innovation. The settlement of a significant securities lawsuit removes a major legal uncertainty.
At the time of this filing, DOCS was trading at $19.26 on NYSE in the Technology sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $17.15 to $76.51. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.